176174-98-4 Usage
Molecular structure
The compound consists of an indole ring attached to a propanoic acid group, a bromophenylmethyl group, and a methoxy-methyl group.
Derivative
It is a derivative of the indole-3-propanoic acid.
Substitution
The structure contains a substituted bromophenylmethyl group and a methoxy-methyl group.
Pharmaceutical and research applications
The compound is used as a potential drug candidate for various therapeutic uses, including as an anti-inflammatory agent and in the treatment of psychiatric and neurological disorders.
Potential for further investigation
The compound's structure and properties make it a potential candidate for further investigation in drug development and medicinal chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 176174-98-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,6,1,7 and 4 respectively; the second part has 2 digits, 9 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 176174-98:
(8*1)+(7*7)+(6*6)+(5*1)+(4*7)+(3*4)+(2*9)+(1*8)=164
164 % 10 = 4
So 176174-98-4 is a valid CAS Registry Number.
176174-98-4Relevant academic research and scientific papers
N-benzylindol-3-yl propanoic acid derivatives as cyclooxygenase inhibitors
-
, (2008/06/13)
The invention encompasses the novel compound of Formula I as well as a method of treating cyclooxygenase-2 mediated diseases comprising administration to a patient in need of such treatment of a non-toxic therapeutically effective amount of a compound of
From indomethacin to a selective COX-2 inhibitor: Development of indolalkanoic acids as potent and selective cyclooxygenase-2-inhibitors
Black,Bayly,Belley,Chan,Charleson,Denis,Gauthier,Gordon,Guay,Kargman,Lau,Leblanc,Mancini,Ouellet,Percival,Roy,Skorey,Tagari,Vickers,et al.
, p. 725 - 730 (2007/10/03)
A series of potent and highly selective cyclooxygenase-2 inhibitors have been prepared by replacing the benzoyl group of indomethacin with a 4-bromobenzyl group, and by extending the acetic acid side chain. These compounds show anti-inflammatory activity in rats with no evidence of GI toxicity, even at high doses.
